Morepen Laboratories Limited (MOREPENLAB.BO)
INR 83.77
(-0.35%)
INR 83.77
(-0.35%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 17.01 Billion | 14.13 Billion | 15.41 Billion | 11.75 Billion | 8.39 Billion | 7.56 Billion |
| Cost of Revenue | 10.85 Billion | 9.7 Billion | 10.6 Billion | 7.86 Billion | 5.61 Billion | 4.98 Billion |
| Gross Profit | 6.16 Billion | 4.43 Billion | 4.8 Billion | 3.88 Billion | 2.77 Billion | 2.57 Billion |
| Operating Expenses | 1.98 Billion | 3.91 Billion | 3.71 Billion | 3 Billion | 2.46 Billion | 2.29 Billion |
| Selling, General and Administrative Expenses | 1.93 Billion | 803.35 Million | 677.64 Million | 618.27 Million | 546.62 Million | 480.23 Million |
| Research and Development Expenses | 51.98 Million | 30.68 Million | 30.08 Million | 56.46 Million | 25.46 Million | 9.58 Million |
| Other Expenses | - | 44.76 Million | 89.77 Million | 99.34 Million | 52.87 Million | 28.49 Million |
| Cost and Expenses | 12.84 Billion | 13.62 Billion | 14.32 Billion | 10.87 Billion | 8.07 Billion | 7.28 Billion |
| Operating Income | 4.17 Billion | 484.61 Million | 1.25 Billion | 924.26 Million | 194.8 Million | 166.79 Million |
| Interest Expense | 37.1 Million | 19.8 Million | 24.26 Million | 12.99 Million | 14.95 Million | 16.13 Million |
| Income Tax Expense | 387.95 Million | 170.79 Million | 250.21 Million | 14.21 Million | 55.28 Million | 3.36 Million |
| Earnings before Tax | 1.35 Billion | 557.55 Million | 1.26 Billion | 985.11 Million | 391.07 Million | 291.76 Million |
| Net Income | 961.59 Million | 386.75 Million | 1.01 Billion | 970.85 Million | 335.79 Million | 288.49 Million |
| Earnings Per Share Basic | 1.88 | 0.77 | 2.26 | 2.16 | 0.75 | 0.64 |
| Earnings Per Share Diluted | 1.88 | 0.77 | 1.96 | 2.15 | 0.75 | 0.64 |
| Weighted Average Shares Outstanding | 511.48 Million | 502.2 Million | 449.97 Million | 449.82 Million | 449.82 Million | 449.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 511.16 Million | 502.2 Million | 519.82 Million | 451.07 Million | 449.82 Million | 449.82 Million |
| Gross Margin | 0.36 | 0.31 | 0.31 | 0.33 | 0.33 | 0.34 |
| EBIT Margin | 0.10 | 0.06 | 0.10 | 0.11 | 0.09 | 0.09 |
| Profit Margin | 0.06 | 0.03 | 0.07 | 0.08 | 0.04 | 0.04 |
| EBITDA | 1.72 Billion | 856.66 Million | 1.56 Billion | 1.28 Billion | 779.98 Million | 711.89 Million |
| Earnings Before Tax Margin | 0.25 | 0.03 | 0.08 | 0.08 | 0.02 | 0.02 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 4.55 Billion | 4.23 Billion | 16.9 Billion | 4.44 Billion | 4.21 Billion | 4.01 Billion |
| Cost of Revenue | 3.45 Billion | 3.24 Billion | 13.11 Billion | 2.72 Billion | 2.72 Billion | 2.61 Billion |
| Gross Profit | 1.09 Billion | 987.85 Million | 3.78 Billion | 1.72 Billion | 1.48 Billion | 1.39 Billion |
| Operating Expenses | 635.58 Million | 600.28 Million | 2.53 Billion | 1.3 Billion | 1.23 Billion | 1.21 Billion |
| Selling, General and Administrative Expenses | 635.58 Million | 600.28 Million | - | 318.7 Million | 309.18 Million | 286.76 Million |
| Research and Development Expenses | - | 51.98 Million | - | - | - | - |
| Other Expenses | 34.27 Million | 42.43 Million | 139.7 Million | 40.7 Million | 32.37 Million | 24.19 Million |
| Cost and Expenses | 4.09 Billion | 3.84 Billion | 15.65 Billion | 4.02 Billion | 3.95 Billion | 3.82 Billion |
| Operating Income | 458.91 Million | 387.56 Million | 1.25 Billion | 421.21 Million | 259.02 Million | 183.74 Million |
| Interest Expense | 11.51 Million | 7.98 Million | 37.1 Million | 21.71 Million | 4.57 Million | 2.82 Million |
| Income Tax Expense | 119.98 Million | 134.6 Million | 387.95 Million | 120.29 Million | 74.25 Million | 58.78 Million |
| Earnings before Tax | 481.66 Million | 422.01 Million | 1.35 Billion | 440.2 Million | 286.81 Million | 205.11 Million |
| Net Income | 361.67 Million | 282.8 Million | 961.59 Million | 319.9 Million | 212.56 Million | 146.33 Million |
| Earnings Per Share Basic | 0.71 | 0.54 | - | 0.63 | 0.42 | 0.29 |
| Earnings Per Share Diluted | 0.71 | 0.54 | - | 0.63 | 0.42 | 0.29 |
| Weighted Average Shares Outstanding | 511.16 Million | 511.16 Million | 511.48 Million | 511.16 Million | 511.16 Million | 511.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 511.16 Million | 511.16 Million | 511.48 Million | 511.16 Million | 511.16 Million | 511.13 Million |
| Gross Margin | 0.24 | 0.23 | 0.22 | 0.39 | 0.35 | 0.35 |
| EBIT Margin | 0.11 | 0.11 | - | 0.12 | 0.09 | 0.07 |
| Profit Margin | 0.08 | 0.07 | 0.06 | 0.07 | 0.05 | 0.04 |
| EBITDA | 516.18 Million | 483.8 Million | - | 546.37 Million | 368.26 Million | 285.08 Million |
| Earnings Before Tax Margin | 0.10 | 0.09 | 0.07 | 0.09 | 0.06 | 0.05 |
SKUFF
1396
SLH
VEERHEALTH
BOTJ
XOSWW